Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

6 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

4(57.1%)

Phase 3

2(28.6%)

N/A

1(14.3%)

7Total

Phase 4(4)

Phase 3(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07256977Not ApplicableNot Yet Recruiting

Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

Role: collaborator

NCT00922480Phase 3Completed

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Role: collaborator

NCT02186093Unknown

Clinical, Physiological and Prognostic Implication of Microvascular Status

Role: collaborator

NCT01378104Phase 4Completed

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Role: collaborator

NCT01135212Phase 3Completed

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Role: collaborator

NCT01414361Unknown

Fractional Flow Reserve and Intravascular Ultrasound in Evaluating Intermediate Coronary Lesions

Role: collaborator

NCT01133015Phase 4Unknown

Comparison of Fractional Flow Reserve and Intravascular Ultrasound

Role: collaborator

NCT00823550Phase 4Unknown

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

Role: collaborator

NCT00386529Phase 4Completed

Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients

Role: collaborator

All 9 trials loaded